<VariationArchive VariationID="2203131" VariationName="NM_001128178.3(NPHP1):c.84_87del (p.Ser29fs)" VariationType="Deletion" Accession="VCV002203131" Version="3" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-07-29" DateCreated="2023-02-08" MostRecentSubmission="2024-07-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1925359" VariationID="2203131">
      <GeneList>
        <Gene Symbol="NPHP1" FullName="nephrocystin 1" GeneID="4867" HGNC_ID="HGNC:7905" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2q13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="110123348" stop="110205013" display_start="110123348" display_stop="110205013" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="110880912" stop="110962638" display_start="110880912" display_stop="110962638" Strand="-" />
          </Location>
          <OMIM>607100</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001128178.3(NPHP1):c.84_87del (p.Ser29fs)</Name>
      <CanonicalSPDI>NC_000002.12:110201476:AGAAAG:AG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2q13</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="110201477" stop="110201480" display_start="110201477" display_stop="110201480" variantLength="4" positionVCF="110201476" referenceAlleleVCF="CAGAA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="110959054" stop="110959057" display_start="110959054" display_stop="110959057" variantLength="4" positionVCF="110959053" referenceAlleleVCF="CAGAA" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>S29fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.110959056_110959059del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.110959056_110959059del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.110201479_110201482del" Assembly="GRCh38">
            <Expression>NC_000002.12:g.110201479_110201482del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008287.1" sequenceAccession="NG_008287" sequenceVersion="1" change="g.8583_8586del">
            <Expression>NG_008287.1:g.8583_8586del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000272.5" sequenceAccession="NM_000272" sequenceVersion="5" change="c.84_87del">
            <Expression>NM_000272.5:c.84_87del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000263.2" sequenceAccession="NP_000263" sequenceVersion="2" change="p.Ser29fs">
            <Expression>NP_000263.2:p.Ser29fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001128178.3" sequenceAccession="NM_001128178" sequenceVersion="3" change="c.84_87del" MANESelect="true">
            <Expression>NM_001128178.3:c.84_87del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001121650.1" sequenceAccession="NP_001121650" sequenceVersion="1" change="p.Ser29fs">
            <Expression>NP_001121650.1:p.Ser29fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001128179.3" sequenceAccession="NM_001128179" sequenceVersion="3" change="c.84_87del">
            <Expression>NM_001128179.3:c.84_87del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001121651.1" sequenceAccession="NP_001121651" sequenceVersion="1" change="p.Ser29fs">
            <Expression>NP_001121651.1:p.Ser29fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001374256.1" sequenceAccession="NM_001374256" sequenceVersion="1" change="c.84_87del">
            <Expression>NM_001374256.1:c.84_87del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001361185.1" sequenceAccession="NP_001361185" sequenceVersion="1" change="p.Ser29fs">
            <Expression>NP_001361185.1:p.Ser29fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001374257.1" sequenceAccession="NM_001374257" sequenceVersion="1" change="c.84_87del">
            <Expression>NM_001374257.1:c.84_87del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001361186.1" sequenceAccession="NP_001361186" sequenceVersion="1" change="p.Ser29fs">
            <Expression>NP_001361186.1:p.Ser29fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_207181.4" sequenceAccession="NM_207181" sequenceVersion="4" change="c.84_87del">
            <Expression>NM_207181.4:c.84_87del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_997064.2" sequenceAccession="NP_997064" sequenceVersion="2" change="p.Ser29fs">
            <Expression>NP_997064.2:p.Ser29fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001128178.1" sequenceAccession="NM_001128178" sequenceVersion="1" change="c.84_87delTTCT">
            <Expression>NM_001128178.1:c.84_87delTTCT</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001128178.3(NPHP1):c.84_87del (p.Ser29fs) AND Nephronophthisis" Accession="RCV002634387" Version="2">
        <ClassifiedConditionList TraitSetID="16865">
          <ClassifiedCondition DB="MedGen" ID="C0687120">Nephronophthisis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-02-03" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001128178.3(NPHP1):c.84_87del (p.Ser29fs) AND Nephronophthisis 1" Accession="RCV004594672" Version="1">
        <ClassifiedConditionList TraitSetID="911">
          <ClassifiedCondition DB="MedGen" ID="C1855681">Nephronophthisis 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-07-17" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-07-17" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2023-02-08" MostRecentSubmission="2024-07-23">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16762963</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23559409</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28002029</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="911" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3445" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Nephronophthisis 1</ElementValue>
                <XRef ID="21201" DB="GeneTests" />
                <XRef ID="Nephronophthisis+1/5141" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009728" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Nephronophthisis familial juvenile</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">NPH1</ElementValue>
                <XRef Type="MIM" ID="256100" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">NPHP1</ElementValue>
                <XRef Type="MIM" ID="256100" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The nephronophthisis (NPH) phenotype is characterized by reduced renal concentrating ability, chronic tubulointerstitial nephritis, cystic renal disease, and progression to end-stage renal disease (ESRD) before age 30 years. Three age-based clinical subtypes are recognized: infantile, juvenile, and adolescent/adult. Infantile NPH can present in utero with oligohydramnios sequence (limb contractures, pulmonary hypoplasia, and facial dysmorphisms) or postnatally with renal manifestations that progress to ESRD before age 3 years. Juvenile NPH, the most prevalent subtype, typically presents with polydipsia and polyuria, growth retardation, chronic iron-resistant anemia, or other findings related to chronic kidney disease (CKD). Hypertension is typically absent due to salt wasting. ESRD develops at a median age of 13 years. Ultrasound findings are increased echogenicity, reduced corticomedullary differentiation, and renal cysts (in 50% of affected individuals). Histologic findings include tubulointerstitial fibrosis, thickened and disrupted tubular basement membrane, sporadic corticomedullary cysts, and normal or reduced kidney size. Adolescent/adult NPH is clinically similar to juvenile NPH, but ESRD develops at a median age of 19 years. Within a subtype, inter- and intrafamilial variability in rate of progression to ESRD is considerable. Approximately 80%-90% of individuals with the NPH phenotype have no extrarenal features (i.e., they have isolated NPH); ~10%-20% have extrarenal manifestations that constitute a recognizable syndrome (e.g., Joubert syndrome, Bardet-Biedl syndrome, Jeune syndrome and related skeletal disorders, Meckel-Gruber syndrome, Senior-Løken syndrome, Leber congenital amaurosis, COACH syndrome, and oculomotor apraxia, Cogan type).</Attribute>
                <XRef ID="NBK368475" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18645" />
                <XRef ID="18645" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">27336129</ID>
                <ID Source="BookShelf">NBK368475</ID>
              </Citation>
              <XRef ID="655" DB="Orphanet" />
              <XRef ID="93592" DB="Orphanet" />
              <XRef ID="C1855681" DB="MedGen" />
              <XRef ID="MONDO:0009728" DB="MONDO" />
              <XRef Type="MIM" ID="256100" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="16865" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16739" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Nephronophthisis</ElementValue>
                <XRef ID="72016" DB="GeneTests" />
                <XRef ID="HP:0000090" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0019005" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS256100" DB="OMIM" />
                <XRef ID="204958008" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">juvenile nephronophthisis</ElementValue>
                <XRef ID="HP:0000090" DB="Human Phenotype Ontology" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The nephronophthisis (NPH) phenotype is characterized by reduced renal concentrating ability, chronic tubulointerstitial nephritis, cystic renal disease, and progression to end-stage renal disease (ESRD) before age 30 years. Three age-based clinical subtypes are recognized: infantile, juvenile, and adolescent/adult. Infantile NPH can present in utero with oligohydramnios sequence (limb contractures, pulmonary hypoplasia, and facial dysmorphisms) or postnatally with renal manifestations that progress to ESRD before age 3 years. Juvenile NPH, the most prevalent subtype, typically presents with polydipsia and polyuria, growth retardation, chronic iron-resistant anemia, or other findings related to chronic kidney disease (CKD). Hypertension is typically absent due to salt wasting. ESRD develops at a median age of 13 years. Ultrasound findings are increased echogenicity, reduced corticomedullary differentiation, and renal cysts (in 50% of affected individuals). Histologic findings include tubulointerstitial fibrosis, thickened and disrupted tubular basement membrane, sporadic corticomedullary cysts, and normal or reduced kidney size. Adolescent/adult NPH is clinically similar to juvenile NPH, but ESRD develops at a median age of 19 years. Within a subtype, inter- and intrafamilial variability in rate of progression to ESRD is considerable. Approximately 80%-90% of individuals with the NPH phenotype have no extrarenal features (i.e., they have isolated NPH); ~10%-20% have extrarenal manifestations that constitute a recognizable syndrome (e.g., Joubert syndrome, Bardet-Biedl syndrome, Jeune syndrome and related skeletal disorders, Meckel-Gruber syndrome, Senior-Løken syndrome, Leber congenital amaurosis, COACH syndrome, and oculomotor apraxia, Cogan type).</Attribute>
                <XRef ID="NBK368475" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="206" />
                <XRef ID="206" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">27336129</ID>
                <ID Source="BookShelf">NBK368475</ID>
              </Citation>
              <XRef ID="655" DB="Orphanet" />
              <XRef ID="C0687120" DB="MedGen" />
              <XRef ID="MONDO:0019005" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS256100" DB="OMIM" />
              <XRef Type="primary" ID="HP:0000090" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0004748" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="6213901" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="4832151|MedGen:C0687120" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003524677" DateUpdated="2024-02-14" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-02-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23559409</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28002029</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23559409</ID>
          </Citation>
          <Comment>This premature translational stop signal has been observed in individual(s) with nephronophthisis or nephronophthisis-related ciliopathy (PMID: 23559409, 28002029). This sequence change creates a premature translational stop signal (p.Ser29Argfs*4) in the NPHP1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NPHP1 are known to be pathogenic (PMID: 23559409). This variant is present in population databases (no rsID available, gnomAD 0.007%). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NPHP1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.110959054_110959057del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0687120" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9873651" SubmissionDate="2024-07-18" DateLastUpdated="2024-07-23" DateCreated="2024-07-23">
        <ClinVarSubmissionID localKey="vcgs/unit_1/hg38_NM_001128178_1_NPHP1_c_84_87delTTCT" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV005086258" DateUpdated="2024-07-23" DateCreated="2024-07-23" Type="SCV" Version="1" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-07-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16762963</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23559409</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28002029</ID>
          </Citation>
          <Comment>Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with Joubert syndrome 4 (MIM#609583), nephronophthisis 1, juvenile (MIM#256100) and Senior-Loken syndrome-1 (MIM#266900). (I) 0106 - This gene is associated with autosomal recessive disease. (I) 0204 - Variant is predicted to result in a truncated protein (premature termination codon is located within the first 102 nucleotides of the coding sequence and is predicted to escape nonsense-mediated decay (NMD)). (SP) 0253 - This variant is suspected hemizygous. A potential overlapping deletion has been detected. (I) 0304 - Variant is present in gnomAD (v2, v3) &lt;0.01 for a recessive condition (1 heterozygote, 0 homozygotes). (SP) 0703 - Other 5’ NMD-escape variants comparable to the one identified in this case have moderate previous evidence for pathogenicity. These variants have been reported as pathogenic, and observed in at least one compound heterozygous individual with nephronophthisis (PMID: 16762963). (SP) 0802 - This variant has moderate previous evidence of pathogenicity in unrelated individuals. This variant has been reported as pathogenic (ClinVar), and observed in a compound heterozygous and a homozygous individual with nephronophthisis or nephronophthisis-related ciliopathy (PMID: 28002029, PMID: 23559409). (SP) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NPHP1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_21468</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001128178.1:c.84_87delTTCT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="256100" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_45</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="6213901" TraitType="Disease" MappingType="XRef" MappingValue="C0687120" MappingRef="MedGen">
        <MedGen CUI="C0687120" Name="Nephronophthisis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9873651" TraitType="Disease" MappingType="XRef" MappingValue="256100" MappingRef="OMIM">
        <MedGen CUI="C1855681" Name="Nephronophthisis 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

